Search This Blog

Monday, August 10, 2020

ChemoCentryx, Inc. EPS beats by $0.63, beats on revenue

ChemoCentryx, Inc. (NASDAQ:CCXI): Q2 GAAP EPS of $0.29 beats by $0.63.
Revenue of $49.44M (+589.5% Y/Y) beats by $41.19M.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)